Area 3 of 4 · Proposed research direction
Newborn sickle-cell screening
Primary-health and maternity pathways
Thematic alignment assessed by Axum; not an endorsement or funding commitment from the United Nations.
Research question
How can screening lead reliably to confirmed diagnosis and enrolment in care?
Product direction
A specimen-tracking system with quality checks at the point of testing.
What needs to be established
Measure lost samples and completed referrals against the current workflow.
Evidence and further reading
Nigerian screening feasibility study · 2020 ↗The source provides context or existing research. The proposed product direction is an Axum discovery hypothesis, not a finding that a new invention is patentable.
AXUM FUNDING
Funding allocated to this research area
Not yet reported
No verified Axum allocation has been published for newborn sickle-cell screening. This is not a statement that funding is zero.
This section covers funding allocated through Axum. Supporter pledges and external research funding are excluded.
Discuss supporting this research →